Target intelligence / Profile preview

MHC class I chain-related protein B (MICB)

Target
MICB
Molecular classification
Receptor ligand (ligand for immunoreceptor NKG2D), Major histocompatibility complex (MHC) family (non-classical MHC class I molecule), Cell surface glycoprotein
01

Overview

MHC class I chain-related protein B (MICB) is a non-classical MHC class I molecule that is encoded by the MICB gene on chromosome 6. It structurally resembles classical MHC class I proteins but does not present antigen peptides; instead, it serves as a stress-induced ligand for the activating immunoreceptor NKG2D, which is found on NK cells and some cytotoxic T cells[2][3][7]. MICB expression is upregulated in response to cellular stress, transformation, and infection, and is predominantly localized intracellularly with only limited cell surface expression in both normal and tumor tissues[4]. Its main biological function is to signal distress and promote immune-mediated elimination of abnormal cells. Variations in MICB have been associated with susceptibility to infection and tumors, making it an attractive, though challenging, immunotherapeutic target[4][6][7].

Other names
MHC class I polypeptide-related sequence BMICBMajor histocompatibility complex class I chain-related BMHC class I homolog MICB
02

Mechanism of action

Monoclonal antibodies aimed at MICB or MICA/B may block interaction with NKG2D or modulate immune activity. Immune checkpoint modulation, indirectly through manipulation of MICB-mediated activation of NK and T cells. Antibody-dependent cellular cytotoxicity (potential mechanism for future antibody drugs).

03

Biological functions

Immune response (activation of cytolytic responses of NK cells and some T cells via NKG2D)Cellular stress response (expression induced by cell stress, infection, or transformation)Tumor surveillance (acts as a “kill me” signal for immune cells)Regulation of cytotoxic lymphocyte activity
04

Disease associations

Cancer (expression in tumor cells acts as immune recognition signal)[4]Infection (implicated in viral diseases such as dengue susceptibility)[6]Inflammation (linked to immune system activation)Other: Organ transplantation, autoimmune conditions (role not fully clarified)
05

Safety considerations

Potential for off-target immune activation if therapies excessively stimulate cytotoxic lymphocytes, leading to tissue damage or autoimmune phenomena[4]Limited cell surface expression in normal tissues may complicate targeted therapies—risk of affecting healthy epithelia[4]Allelic and expression heterogeneity across individuals and tissues[^4]
06

Interacting drugs

No approved drugs directly target MICB as the primary molecule; however, MICB is being explored as a therapeutic target in cancer immunotherapy and transplant contexts (experimental monoclonal antibodies and immune-modulating agents)[4]
07

Biomarkers

MICB expression (tissue or serum) is a biomarker for cellular stress, tumor immunogenicity, and organ transplant rejection risk[4][1]Soluble MICB (sMICB) may be monitored in clinical contexts as a marker of immune activity or disease progression[1]

Beyond the preview

Go deeper on MHC class I chain-related protein B (MICB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MHC class I chain-related protein B (MICB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call